#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=EEG coherence related to fMRI resting state synchrony in long-term abstinent alcoholics Recent work suggests that faulty co-activation or synchrony of multiple brain regions comprising “ networks, ” or an imbalance between opposing brain networks, is important in alcoholism.
1-1	0-3	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
1-2	4-13	coherence	_
1-3	14-21	related	_
1-4	22-24	to	_
1-5	25-29	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-6	30-37	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-7	38-43	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-8	44-53	synchrony	_
1-9	54-56	in	_
1-10	57-66	long-term	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
1-11	67-76	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
1-12	77-87	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
1-13	88-94	Recent	_
1-14	95-99	work	_
1-15	100-108	suggests	_
1-16	109-113	that	_
1-17	114-120	faulty	_
1-18	121-134	co-activation	_
1-19	135-137	or	_
1-20	138-147	synchrony	_
1-21	148-150	of	_
1-22	151-159	multiple	_
1-23	160-165	brain	_
1-24	166-173	regions	_
1-25	174-184	comprising	_
1-26	185-186	“	_
1-27	187-195	networks	_
1-28	196-197	,	_
1-29	198-199	”	_
1-30	200-202	or	_
1-31	203-205	an	_
1-32	206-215	imbalance	_
1-33	216-223	between	_
1-34	224-232	opposing	_
1-35	233-238	brain	_
1-36	239-247	networks	_
1-37	248-249	,	_
1-38	250-252	is	_
1-39	253-262	important	_
1-40	263-265	in	_
1-41	266-276	alcoholism	_
1-42	277-278	.	_

Text=Previous studies showed higher fMRI resting state synchrony (RSS) within the executive control (inhibitory control and emotion regulation) networks and lower RSS within the appetitive drive network in long-term (multi-year) abstinent alcoholics (LTAA) vs. non substance abusing controls (NSAC).
2-1	279-287	Previous	_
2-2	288-295	studies	_
2-3	296-302	showed	_
2-4	303-309	higher	_
2-5	310-314	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-6	315-322	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-7	323-328	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-8	329-338	synchrony	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-9	339-340	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-10	341-344	RSS	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-11	345-346	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-12	347-353	within	_
2-13	354-357	the	_
2-14	358-367	executive	_
2-15	368-375	control	_
2-16	376-377	(	_
2-17	378-388	inhibitory	_
2-18	389-396	control	_
2-19	397-400	and	_
2-20	401-408	emotion	_
2-21	409-419	regulation	_
2-22	420-421	)	_
2-23	422-430	networks	_
2-24	431-434	and	_
2-25	435-440	lower	_
2-26	441-444	RSS	_
2-27	445-451	within	_
2-28	452-455	the	_
2-29	456-466	appetitive	_
2-30	467-472	drive	_
2-31	473-480	network	_
2-32	481-483	in	_
2-33	484-493	long-term	_
2-34	494-495	(	_
2-35	496-506	multi-year	_
2-36	507-508	)	_
2-37	509-518	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
2-38	519-529	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
2-39	530-531	(	_
2-40	532-536	LTAA	_
2-41	537-538	)	_
2-42	539-542	vs.	_
2-43	543-546	non	_
2-44	547-556	substance	_
2-45	557-564	abusing	_
2-46	565-573	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-47	574-575	(	_
2-48	576-580	NSAC	_
2-49	581-582	)	_
2-50	583-584	.	_

Text=Our goal was to identify EEG networks that are correlated with the appetitive drive and executive function networks identified with fMRI in our previous alcohol studies.
3-1	585-588	Our	_
3-2	589-593	goal	_
3-3	594-597	was	_
3-4	598-600	to	_
3-5	601-609	identify	_
3-6	610-613	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
3-7	614-622	networks	_
3-8	623-627	that	_
3-9	628-631	are	_
3-10	632-642	correlated	_
3-11	643-647	with	_
3-12	648-651	the	_
3-13	652-662	appetitive	_
3-14	663-668	drive	_
3-15	669-672	and	_
3-16	673-682	executive	_
3-17	683-691	function	_
3-18	692-700	networks	_
3-19	701-711	identified	_
3-20	712-716	with	_
3-21	717-721	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-22	722-724	in	_
3-23	725-728	our	_
3-24	729-737	previous	_
3-25	738-745	alcohol	_
3-26	746-753	studies	_
3-27	754-755	.	_

Text=We used parallel ICA for multimodal data fusion for the 20 LTAA and 21 NSAC that had both usable fMRI and 64-channel EEG data.
4-1	756-758	We	_
4-2	759-763	used	_
4-3	764-772	parallel	_
4-4	773-776	ICA	_
4-5	777-780	for	_
4-6	781-791	multimodal	_
4-7	792-796	data	_
4-8	797-803	fusion	_
4-9	804-807	for	_
4-10	808-811	the	_
4-11	812-814	20	_
4-12	815-819	LTAA	_
4-13	820-823	and	_
4-14	824-826	21	_
4-15	827-831	NSAC	_
4-16	832-836	that	_
4-17	837-840	had	_
4-18	841-845	both	_
4-19	846-852	usable	_
4-20	853-857	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-21	858-861	and	_
4-22	862-872	64-channel	_
4-23	873-876	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
4-24	877-881	data	_
4-25	882-883	.	_

Text=Our major result was that parallel ICA identified a pair of components that significantly separated NSAC from LTAA and were correlated with each other.
5-1	884-887	Our	_
5-2	888-893	major	_
5-3	894-900	result	_
5-4	901-904	was	_
5-5	905-909	that	_
5-6	910-918	parallel	_
5-7	919-922	ICA	_
5-8	923-933	identified	_
5-9	934-935	a	_
5-10	936-940	pair	_
5-11	941-943	of	_
5-12	944-954	components	_
5-13	955-959	that	_
5-14	960-973	significantly	_
5-15	974-983	separated	_
5-16	984-988	NSAC	_
5-17	989-993	from	_
5-18	994-998	LTAA	_
5-19	999-1002	and	_
5-20	1003-1007	were	_
5-21	1008-1018	correlated	_
5-22	1019-1023	with	_
5-23	1024-1028	each	_
5-24	1029-1034	other	_
5-25	1035-1036	.	_

Text=Examination of the resting-state fMRI seed-correlation map component showed higher bilateral nucleus accumbens seed-correlation in the dorsolateral prefrontal cortex bilaterally and lower seed-correlation in the thalamus.
6-1	1037-1048	Examination	_
6-2	1049-1051	of	_
6-3	1052-1055	the	_
6-4	1056-1069	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
6-5	1070-1074	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
6-6	1075-1091	seed-correlation	_
6-7	1092-1095	map	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence
6-8	1096-1105	component	_
6-9	1106-1112	showed	_
6-10	1113-1119	higher	_
6-11	1120-1129	bilateral	_
6-12	1130-1137	nucleus	_
6-13	1138-1147	accumbens	_
6-14	1148-1164	seed-correlation	_
6-15	1165-1167	in	_
6-16	1168-1171	the	_
6-17	1172-1184	dorsolateral	_
6-18	1185-1195	prefrontal	_
6-19	1196-1202	cortex	_
6-20	1203-1214	bilaterally	_
6-21	1215-1218	and	_
6-22	1219-1224	lower	_
6-23	1225-1241	seed-correlation	_
6-24	1242-1244	in	_
6-25	1245-1248	the	_
6-26	1249-1257	thalamus	_
6-27	1258-1259	.	_

Text=This single component thus encompassed both the executive control and appetitive drive networks, consistent with our previous work.
7-1	1260-1264	This	_
7-2	1265-1271	single	_
7-3	1272-1281	component	_
7-4	1282-1286	thus	_
7-5	1287-1298	encompassed	_
7-6	1299-1303	both	_
7-7	1304-1307	the	_
7-8	1308-1317	executive	_
7-9	1318-1325	control	_
7-10	1326-1329	and	_
7-11	1330-1340	appetitive	_
7-12	1341-1346	drive	_
7-13	1347-1355	networks	_
7-14	1356-1357	,	_
7-15	1358-1368	consistent	_
7-16	1369-1373	with	_
7-17	1374-1377	our	_
7-18	1378-1386	previous	_
7-19	1387-1391	work	_
7-20	1392-1393	.	_

Text=The correlated EEG coherence component showed mostly higher theta and alpha coherence in LTAA compared to NSAC, and lower gamma coherence in LTAA compared to NSAC.
8-1	1394-1397	The	_
8-2	1398-1408	correlated	_
8-3	1409-1412	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
8-4	1413-1422	coherence	_
8-5	1423-1432	component	_
8-6	1433-1439	showed	_
8-7	1440-1446	mostly	_
8-8	1447-1453	higher	_
8-9	1454-1459	theta	_
8-10	1460-1463	and	_
8-11	1464-1469	alpha	_
8-12	1470-1479	coherence	_
8-13	1480-1482	in	_
8-14	1483-1487	LTAA	_
8-15	1488-1496	compared	_
8-16	1497-1499	to	_
8-17	1500-1504	NSAC	_
8-18	1505-1506	,	_
8-19	1507-1510	and	_
8-20	1511-1516	lower	_
8-21	1517-1522	gamma	_
8-22	1523-1532	coherence	_
8-23	1533-1535	in	_
8-24	1536-1540	LTAA	_
8-25	1541-1549	compared	_
8-26	1550-1552	to	_
8-27	1553-1557	NSAC	_
8-28	1558-1559	.	_

Text=The EEG theta and alpha coherence results suggest enhanced top-down control in LTAA and the gamma coherence results suggest impaired appetitive drive in LTAA.
9-1	1560-1563	The	_
9-2	1564-1567	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
9-3	1568-1573	theta	_
9-4	1574-1577	and	_
9-5	1578-1583	alpha	_
9-6	1584-1593	coherence	_
9-7	1594-1601	results	_
9-8	1602-1609	suggest	_
9-9	1610-1618	enhanced	_
9-10	1619-1627	top-down	_
9-11	1628-1635	control	_
9-12	1636-1638	in	_
9-13	1639-1643	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#DataAnalysisMethod
9-14	1644-1647	and	_
9-15	1648-1651	the	_
9-16	1652-1657	gamma	_
9-17	1658-1667	coherence	_
9-18	1668-1675	results	_
9-19	1676-1683	suggest	_
9-20	1684-1692	impaired	_
9-21	1693-1703	appetitive	_
9-22	1704-1709	drive	_
9-23	1710-1712	in	_
9-24	1713-1717	LTAA	_
9-25	1718-1719	.	_

Text=Our results support the notion that fMRI RSS is reflected in spontaneous EEG, even when the EEG and fMRI are not obtained simultaneously.
10-1	1720-1723	Our	_
10-2	1724-1731	results	_
10-3	1732-1739	support	_
10-4	1740-1743	the	_
10-5	1744-1750	notion	_
10-6	1751-1755	that	_
10-7	1756-1760	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-8	1761-1764	RSS	_
10-9	1765-1767	is	_
10-10	1768-1777	reflected	_
10-11	1778-1780	in	_
10-12	1781-1792	spontaneous	_
10-13	1793-1796	EEG	_
10-14	1797-1798	,	_
10-15	1799-1803	even	_
10-16	1804-1808	when	_
10-17	1809-1812	the	_
10-18	1813-1816	EEG	_
10-19	1817-1820	and	_
10-20	1821-1825	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-21	1826-1829	are	_
10-22	1830-1833	not	_
10-23	1834-1842	obtained	_
10-24	1843-1857	simultaneously	_
10-25	1858-1859	.	_

Text=Highlights fMRI and EEG were obtained for 20 long-term abstinent alcoholics and 21 controls.
11-1	1860-1870	Highlights	_
11-2	1871-1875	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-3	1876-1879	and	_
11-4	1880-1883	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
11-5	1884-1888	were	_
11-6	1889-1897	obtained	_
11-7	1898-1901	for	_
11-8	1902-1904	20	_
11-9	1905-1914	long-term	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
11-10	1915-1924	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
11-11	1925-1935	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
11-12	1936-1939	and	_
11-13	1940-1942	21	_
11-14	1943-1951	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-15	1952-1953	.	_

Text=Parallel ICA was used to identify analogous networks in each modality.
12-1	1954-1962	Parallel	_
12-2	1963-1966	ICA	_
12-3	1967-1970	was	_
12-4	1971-1975	used	_
12-5	1976-1978	to	_
12-6	1979-1987	identify	_
12-7	1988-1997	analogous	_
12-8	1998-2006	networks	_
12-9	2007-2009	in	_
12-10	2010-2014	each	_
12-11	2015-2023	modality	_
12-12	2024-2025	.	_

Text=One pair of components separated groups and were correlated across modalities.
13-1	2026-2029	One	_
13-2	2030-2034	pair	_
13-3	2035-2037	of	_
13-4	2038-2048	components	_
13-5	2049-2058	separated	_
13-6	2059-2065	groups	_
13-7	2066-2069	and	_
13-8	2070-2074	were	_
13-9	2075-2085	correlated	_
13-10	2086-2092	across	_
13-11	2093-2103	modalities	_
13-12	2104-2105	.	_

Text=fMRI component encompassed executive control and appetitive drive networks.
14-1	2106-2110	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
14-2	2111-2120	component	_
14-3	2121-2132	encompassed	_
14-4	2133-2142	executive	_
14-5	2143-2150	control	_
14-6	2151-2154	and	_
14-7	2155-2165	appetitive	_
14-8	2166-2171	drive	_
14-9	2172-2180	networks	_
14-10	2181-2182	.	_

Text=EEG coherence component involves top-down control and appetitive drive.
15-1	2183-2186	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
15-2	2187-2196	coherence	_
15-3	2197-2206	component	_
15-4	2207-2215	involves	_
15-5	2216-2224	top-down	_
15-6	2225-2232	control	_
15-7	2233-2236	and	_
15-8	2237-2247	appetitive	_
15-9	2248-2253	drive	_
15-10	2254-2255	.	_

Text=Methods Participants Twenty-three LTAA (abstinent 7.91 ± 7.80 years) were compared to 23 gender and age (35–60 years) comparable NSAC, as described in.
16-1	2256-2263	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
16-2	2264-2276	Participants	_
16-3	2277-2289	Twenty-three	_
16-4	2290-2294	LTAA	_
16-5	2295-2296	(	_
16-6	2297-2306	abstinent	_
16-7	2307-2311	7.91	_
16-8	2312-2313	±	_
16-9	2314-2318	7.80	_
16-10	2319-2324	years	_
16-11	2325-2326	)	_
16-12	2327-2331	were	_
16-13	2332-2340	compared	_
16-14	2341-2343	to	_
16-15	2344-2346	23	_
16-16	2347-2353	gender	_
16-17	2354-2357	and	_
16-18	2358-2361	age	_
16-19	2362-2363	(	_
16-20	2364-2369	35–60	_
16-21	2370-2375	years	_
16-22	2376-2377	)	_
16-23	2378-2388	comparable	_
16-24	2389-2393	NSAC	_
16-25	2394-2395	,	_
16-26	2396-2398	as	_
16-27	2399-2408	described	_
16-28	2409-2411	in	_
16-29	2412-2413	.	_

Text=LTAA met DSM-IV lifetime criteria for alcohol dependence but not for lifetime abuse or dependence on any other drugs of abuse (other than nicotine or caffeine).
17-1	2414-2418	LTAA	_
17-2	2419-2422	met	_
17-3	2423-2429	DSM-IV	_
17-4	2430-2438	lifetime	_
17-5	2439-2447	criteria	_
17-6	2448-2451	for	_
17-7	2452-2459	alcohol	_
17-8	2460-2470	dependence	_
17-9	2471-2474	but	_
17-10	2475-2478	not	_
17-11	2479-2482	for	_
17-12	2483-2491	lifetime	_
17-13	2492-2497	abuse	_
17-14	2498-2500	or	_
17-15	2501-2511	dependence	_
17-16	2512-2514	on	_
17-17	2515-2518	any	_
17-18	2519-2524	other	_
17-19	2525-2530	drugs	_
17-20	2531-2533	of	_
17-21	2534-2539	abuse	_
17-22	2540-2541	(	_
17-23	2542-2547	other	_
17-24	2548-2552	than	_
17-25	2553-2561	nicotine	_
17-26	2562-2564	or	_
17-27	2565-2573	caffeine	_
17-28	2574-2575	)	_
17-29	2576-2577	.	_

Text=Inclusion criteria for the NSAC group was a lifetime drinking average of <30 standard drinks per month with no periods of drinking> 60 drinks per month, and no lifetime history of alcohol or substance abuse or dependence.
18-1	2578-2587	Inclusion	_
18-2	2588-2596	criteria	_
18-3	2597-2600	for	_
18-4	2601-2604	the	_
18-5	2605-2609	NSAC	_
18-6	2610-2615	group	_
18-7	2616-2619	was	_
18-8	2620-2621	a	_
18-9	2622-2630	lifetime	_
18-10	2631-2639	drinking	_
18-11	2640-2647	average	_
18-12	2648-2650	of	_
18-13	2651-2652	<	_
18-14	2653-2655	30	_
18-15	2656-2664	standard	_
18-16	2665-2671	drinks	_
18-17	2672-2675	per	_
18-18	2676-2681	month	_
18-19	2682-2686	with	_
18-20	2687-2689	no	_
18-21	2690-2697	periods	_
18-22	2698-2700	of	_
18-23	2701-2709	drinking	_
18-24	2710-2711	>	_
18-25	2712-2714	60	_
18-26	2715-2721	drinks	_
18-27	2722-2725	per	_
18-28	2726-2731	month	_
18-29	2732-2733	,	_
18-30	2734-2737	and	_
18-31	2738-2740	no	_
18-32	2741-2749	lifetime	_
18-33	2750-2757	history	_
18-34	2758-2760	of	_
18-35	2761-2768	alcohol	_
18-36	2769-2771	or	_
18-37	2772-2781	substance	_
18-38	2782-2787	abuse	_
18-39	2788-2790	or	_
18-40	2791-2801	dependence	_
18-41	2802-2803	.	_

Text=Participants received monetary compensation for their participation.
19-1	2804-2816	Participants	_
19-2	2817-2825	received	_
19-3	2826-2834	monetary	_
19-4	2835-2847	compensation	_
19-5	2848-2851	for	_
19-6	2852-2857	their	_
19-7	2858-2871	participation	_
19-8	2872-2873	.	_

Text=Exclusion criteria for both groups included: a) a significant history of head trauma or cranial surgery; b) current or lifetime history of diabetes, stroke, or hypertension that required medical intervention; c) current or lifetime history of a significant neurological disorder, including dementia; d) clinical or laboratory evidence of active hepatic disease; e) clinical evidence for Wernicke-Korsakoff syndrome, and f) lifetime diagnosis of schizophrenia or schizophreniform disorder, f) contraindications to MRI.
20-1	2874-2883	Exclusion	_
20-2	2884-2892	criteria	_
20-3	2893-2896	for	_
20-4	2897-2901	both	_
20-5	2902-2908	groups	_
20-6	2909-2917	included	_
20-7	2918-2919	:	_
20-8	2920-2921	a	_
20-9	2922-2923	)	_
20-10	2924-2925	a	_
20-11	2926-2937	significant	_
20-12	2938-2945	history	_
20-13	2946-2948	of	_
20-14	2949-2953	head	_
20-15	2954-2960	trauma	_
20-16	2961-2963	or	_
20-17	2964-2971	cranial	_
20-18	2972-2979	surgery	_
20-19	2980-2981	;	_
20-20	2982-2983	b	_
20-21	2984-2985	)	_
20-22	2986-2993	current	_
20-23	2994-2996	or	_
20-24	2997-3005	lifetime	_
20-25	3006-3013	history	_
20-26	3014-3016	of	_
20-27	3017-3025	diabetes	_
20-28	3026-3027	,	_
20-29	3028-3034	stroke	_
20-30	3035-3036	,	_
20-31	3037-3039	or	_
20-32	3040-3052	hypertension	_
20-33	3053-3057	that	_
20-34	3058-3066	required	_
20-35	3067-3074	medical	_
20-36	3075-3087	intervention	_
20-37	3088-3089	;	_
20-38	3090-3091	c	_
20-39	3092-3093	)	_
20-40	3094-3101	current	_
20-41	3102-3104	or	_
20-42	3105-3113	lifetime	_
20-43	3114-3121	history	_
20-44	3122-3124	of	_
20-45	3125-3126	a	_
20-46	3127-3138	significant	_
20-47	3139-3151	neurological	_
20-48	3152-3160	disorder	_
20-49	3161-3162	,	_
20-50	3163-3172	including	_
20-51	3173-3181	dementia	_
20-52	3182-3183	;	_
20-53	3184-3185	d	_
20-54	3186-3187	)	_
20-55	3188-3196	clinical	_
20-56	3197-3199	or	_
20-57	3200-3210	laboratory	_
20-58	3211-3219	evidence	_
20-59	3220-3222	of	_
20-60	3223-3229	active	_
20-61	3230-3237	hepatic	_
20-62	3238-3245	disease	_
20-63	3246-3247	;	_
20-64	3248-3249	e	_
20-65	3250-3251	)	_
20-66	3252-3260	clinical	_
20-67	3261-3269	evidence	_
20-68	3270-3273	for	_
20-69	3274-3292	Wernicke-Korsakoff	_
20-70	3293-3301	syndrome	_
20-71	3302-3303	,	_
20-72	3304-3307	and	_
20-73	3308-3309	f	_
20-74	3310-3311	)	_
20-75	3312-3320	lifetime	_
20-76	3321-3330	diagnosis	_
20-77	3331-3333	of	_
20-78	3334-3347	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
20-79	3348-3350	or	_
20-80	3351-3367	schizophreniform	_
20-81	3368-3376	disorder	_
20-82	3377-3378	,	_
20-83	3379-3380	f	_
20-84	3381-3382	)	_
20-85	3383-3400	contraindications	_
20-86	3401-3403	to	_
20-87	3404-3407	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
20-88	3408-3409	.	_

Text=All subjects completed signed informed consent, as approved by our institutional review board (E & I Review Services, LLC, Corte Madera, CA), before study procedures commenced.
21-1	3410-3413	All	_
21-2	3414-3422	subjects	_
21-3	3423-3432	completed	_
21-4	3433-3439	signed	_
21-5	3440-3448	informed	_
21-6	3449-3456	consent	_
21-7	3457-3458	,	_
21-8	3459-3461	as	_
21-9	3462-3470	approved	_
21-10	3471-3473	by	_
21-11	3474-3477	our	_
21-12	3478-3491	institutional	_
21-13	3492-3498	review	_
21-14	3499-3504	board	_
21-15	3505-3506	(	_
21-16	3507-3508	E	_
21-17	3509-3510	&	_
21-18	3511-3512	I	_
21-19	3513-3519	Review	_
21-20	3520-3528	Services	_
21-21	3529-3530	,	_
21-22	3531-3534	LLC	_
21-23	3535-3536	,	_
21-24	3537-3542	Corte	_
21-25	3543-3549	Madera	_
21-26	3550-3551	,	_
21-27	3552-3554	CA	_
21-28	3555-3556	)	_
21-29	3557-3558	,	_
21-30	3559-3565	before	_
21-31	3566-3571	study	_
21-32	3572-3582	procedures	_
21-33	3583-3592	commenced	_
21-34	3593-3594	.	_

Text=Participants were studied with fMRI, EEG, clinical, and neuropsychological testing.
22-1	3595-3607	Participants	_
22-2	3608-3612	were	_
22-3	3613-3620	studied	_
22-4	3621-3625	with	_
22-5	3626-3630	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
22-6	3631-3632	,	_
22-7	3633-3636	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
22-8	3637-3638	,	_
22-9	3639-3647	clinical	_
22-10	3648-3649	,	_
22-11	3650-3653	and	_
22-12	3654-3672	neuropsychological	_
22-13	3673-3680	testing	_
22-14	3681-3682	.	_

Text=Ideally, all study procedures were completed within one month, but due to scheduling difficulties time between EEG and fMRI acquisition was sometimes longer.
23-1	3683-3690	Ideally	_
23-2	3691-3692	,	_
23-3	3693-3696	all	_
23-4	3697-3702	study	_
23-5	3703-3713	procedures	_
23-6	3714-3718	were	_
23-7	3719-3728	completed	_
23-8	3729-3735	within	_
23-9	3736-3739	one	_
23-10	3740-3745	month	_
23-11	3746-3747	,	_
23-12	3748-3751	but	_
23-13	3752-3755	due	_
23-14	3756-3758	to	_
23-15	3759-3769	scheduling	_
23-16	3770-3782	difficulties	_
23-17	3783-3787	time	_
23-18	3788-3795	between	_
23-19	3796-3799	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
23-20	3800-3803	and	_
23-21	3804-3808	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
23-22	3809-3820	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
23-23	3821-3824	was	_
23-24	3825-3834	sometimes	_
23-25	3835-3841	longer	_
23-26	3842-3843	.	_

Text=For the 41 participants that had both usable fMRI and EEG, 31 (76%) were acquired within one month, with the time between acquisitions of 6.57 ± 8.24 weeks for NSAC and 4.65 ± 9.48 weeks for LTAA (no difference between groups).
24-1	3844-3847	For	_
24-2	3848-3851	the	_
24-3	3852-3854	41	_
24-4	3855-3867	participants	_
24-5	3868-3872	that	_
24-6	3873-3876	had	_
24-7	3877-3881	both	_
24-8	3882-3888	usable	_
24-9	3889-3893	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
24-10	3894-3897	and	_
24-11	3898-3901	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
24-12	3902-3903	,	_
24-13	3904-3906	31	_
24-14	3907-3908	(	_
24-15	3909-3911	76	_
24-16	3912-3913	%	_
24-17	3914-3915	)	_
24-18	3916-3920	were	_
24-19	3921-3929	acquired	_
24-20	3930-3936	within	_
24-21	3937-3940	one	_
24-22	3941-3946	month	_
24-23	3947-3948	,	_
24-24	3949-3953	with	_
24-25	3954-3957	the	_
24-26	3958-3962	time	_
24-27	3963-3970	between	_
24-28	3971-3983	acquisitions	_
24-29	3984-3986	of	_
24-30	3987-3991	6.57	_
24-31	3992-3993	±	_
24-32	3994-3998	8.24	_
24-33	3999-4004	weeks	_
24-34	4005-4008	for	_
24-35	4009-4013	NSAC	_
24-36	4014-4017	and	_
24-37	4018-4022	4.65	_
24-38	4023-4024	±	_
24-39	4025-4029	9.48	_
24-40	4030-4035	weeks	_
24-41	4036-4039	for	_
24-42	4040-4044	LTAA	_
24-43	4045-4046	(	_
24-44	4047-4049	no	_
24-45	4050-4060	difference	_
24-46	4061-4068	between	_
24-47	4069-4075	groups	_
24-48	4076-4077	)	_
24-49	4078-4079	.	_

Text=LTAA subjects were required to stay sober throughout the study and did not drink between EEG and fMRI acquisitions; NSAC were asked to abstain from alcohol for 24 h prior to any lab visit, but may have continued drinking at their usual low level of drinking between visits and their alcohol use between study procedures was not monitored.
25-1	4080-4084	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#DataAnalysisMethod
25-2	4085-4093	subjects	_
25-3	4094-4098	were	_
25-4	4099-4107	required	_
25-5	4108-4110	to	_
25-6	4111-4115	stay	_
25-7	4116-4121	sober	_
25-8	4122-4132	throughout	_
25-9	4133-4136	the	_
25-10	4137-4142	study	_
25-11	4143-4146	and	_
25-12	4147-4150	did	_
25-13	4151-4154	not	_
25-14	4155-4160	drink	_
25-15	4161-4168	between	_
25-16	4169-4172	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
25-17	4173-4176	and	_
25-18	4177-4181	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
25-19	4182-4194	acquisitions	_
25-20	4195-4196	;	_
25-21	4197-4201	NSAC	_
25-22	4202-4206	were	_
25-23	4207-4212	asked	_
25-24	4213-4215	to	_
25-25	4216-4223	abstain	_
25-26	4224-4228	from	_
25-27	4229-4236	alcohol	_
25-28	4237-4240	for	_
25-29	4241-4243	24	_
25-30	4244-4245	h	_
25-31	4246-4251	prior	_
25-32	4252-4254	to	_
25-33	4255-4258	any	_
25-34	4259-4262	lab	_
25-35	4263-4268	visit	_
25-36	4269-4270	,	_
25-37	4271-4274	but	_
25-38	4275-4278	may	_
25-39	4279-4283	have	_
25-40	4284-4293	continued	_
25-41	4294-4302	drinking	_
25-42	4303-4305	at	_
25-43	4306-4311	their	_
25-44	4312-4317	usual	_
25-45	4318-4321	low	_
25-46	4322-4327	level	_
25-47	4328-4330	of	_
25-48	4331-4339	drinking	_
25-49	4340-4347	between	_
25-50	4348-4354	visits	_
25-51	4355-4358	and	_
25-52	4359-4364	their	_
25-53	4365-4372	alcohol	_
25-54	4373-4376	use	_
25-55	4377-4384	between	_
25-56	4385-4390	study	_
25-57	4391-4401	procedures	_
25-58	4402-4405	was	_
25-59	4406-4409	not	_
25-60	4410-4419	monitored	_
25-61	4420-4421	.	_

Text=A breathalyzer test (Intoximeters, Inc., St. Louis, MO) and a rapid oral fluid drug screen test (Innovacon Inc., San Diego, CA) for THC, amphetamines, methamphetamines, cocaine, opioids, and PCP was administered to all participants, with a negative result required for all participants at all sessions.
26-1	4422-4423	A	_
26-2	4424-4436	breathalyzer	_
26-3	4437-4441	test	_
26-4	4442-4443	(	_
26-5	4444-4456	Intoximeters	_
26-6	4457-4458	,	_
26-7	4459-4463	Inc.	_
26-8	4464-4465	,	_
26-9	4466-4469	St.	_
26-10	4470-4475	Louis	_
26-11	4476-4477	,	_
26-12	4478-4480	MO	_
26-13	4481-4482	)	_
26-14	4483-4486	and	_
26-15	4487-4488	a	_
26-16	4489-4494	rapid	_
26-17	4495-4499	oral	_
26-18	4500-4505	fluid	_
26-19	4506-4510	drug	_
26-20	4511-4517	screen	_
26-21	4518-4522	test	_
26-22	4523-4524	(	_
26-23	4525-4534	Innovacon	_
26-24	4535-4539	Inc.	_
26-25	4540-4541	,	_
26-26	4542-4545	San	_
26-27	4546-4551	Diego	_
26-28	4552-4553	,	_
26-29	4554-4556	CA	_
26-30	4557-4558	)	_
26-31	4559-4562	for	_
26-32	4563-4566	THC	_
26-33	4567-4568	,	_
26-34	4569-4581	amphetamines	_
26-35	4582-4583	,	_
26-36	4584-4600	methamphetamines	_
26-37	4601-4602	,	_
26-38	4603-4610	cocaine	_
26-39	4611-4612	,	_
26-40	4613-4620	opioids	_
26-41	4621-4622	,	_
26-42	4623-4626	and	_
26-43	4627-4630	PCP	_
26-44	4631-4634	was	_
26-45	4635-4647	administered	_
26-46	4648-4650	to	_
26-47	4651-4654	all	_
26-48	4655-4667	participants	_
26-49	4668-4669	,	_
26-50	4670-4674	with	_
26-51	4675-4676	a	_
26-52	4677-4685	negative	_
26-53	4686-4692	result	_
26-54	4693-4701	required	_
26-55	4702-4705	for	_
26-56	4706-4709	all	_
26-57	4710-4722	participants	_
26-58	4723-4725	at	_
26-59	4726-4729	all	_
26-60	4730-4738	sessions	_
26-61	4739-4740	.	_

Text=Clinical and psychological measures Participants were interviewed on the lifetime use of alcohol and each drug that they had taken (including nicotine) using a timeline follow-back and lifetime drinking history assessment.
27-1	4741-4749	Clinical	_
27-2	4750-4753	and	_
27-3	4754-4767	psychological	_
27-4	4768-4776	measures	_
27-5	4777-4789	Participants	_
27-6	4790-4794	were	_
27-7	4795-4806	interviewed	_
27-8	4807-4809	on	_
27-9	4810-4813	the	_
27-10	4814-4822	lifetime	_
27-11	4823-4826	use	_
27-12	4827-4829	of	_
27-13	4830-4837	alcohol	_
27-14	4838-4841	and	_
27-15	4842-4846	each	_
27-16	4847-4851	drug	_
27-17	4852-4856	that	_
27-18	4857-4861	they	_
27-19	4862-4865	had	_
27-20	4866-4871	taken	_
27-21	4872-4873	(	_
27-22	4874-4883	including	_
27-23	4884-4892	nicotine	_
27-24	4893-4894	)	_
27-25	4895-4900	using	_
27-26	4901-4902	a	_
27-27	4903-4911	timeline	_
27-28	4912-4923	follow-back	_
27-29	4924-4927	and	_
27-30	4928-4936	lifetime	_
27-31	4937-4945	drinking	_
27-32	4946-4953	history	_
27-33	4954-4964	assessment	_
27-34	4965-4966	.	_

Text=ASPD symptoms were obtained using the C-DIS.
28-1	4967-4971	ASPD	_
28-2	4972-4980	symptoms	_
28-3	4981-4985	were	_
28-4	4986-4994	obtained	_
28-5	4995-5000	using	_
28-6	5001-5004	the	_
28-7	5005-5010	C-DIS	_
28-8	5011-5012	.	_

Text=For each symptom the subject endorsed, we asked about currency.
29-1	5013-5016	For	_
29-2	5017-5021	each	_
29-3	5022-5029	symptom	_
29-4	5030-5033	the	_
29-5	5034-5041	subject	_
29-6	5042-5050	endorsed	_
29-7	5051-5052	,	_
29-8	5053-5055	we	_
29-9	5056-5061	asked	_
29-10	5062-5067	about	_
29-11	5068-5076	currency	_
29-12	5077-5078	.	_

Text=Psychological measures of antisocial behavior were also assessed.
30-1	5079-5092	Psychological	_
30-2	5093-5101	measures	_
30-3	5102-5104	of	_
30-4	5105-5115	antisocial	_
30-5	5116-5124	behavior	_
30-6	5125-5129	were	_
30-7	5130-5134	also	_
30-8	5135-5143	assessed	_
30-9	5144-5145	.	_

Text=Social deviance proneness was measured by the CPI socialization scale, impulsivity was measured by the Eysenck impulsivity scale, and antisocial disposition was measured by the MMPI psychopathic deviance scale.
31-1	5146-5152	Social	_
31-2	5153-5161	deviance	_
31-3	5162-5171	proneness	_
31-4	5172-5175	was	_
31-5	5176-5184	measured	_
31-6	5185-5187	by	_
31-7	5188-5191	the	_
31-8	5192-5195	CPI	http://maven.renci.org/NeuroBridge/neurobridge#Scale
31-9	5196-5209	socialization	http://maven.renci.org/NeuroBridge/neurobridge#Scale
31-10	5210-5215	scale	http://maven.renci.org/NeuroBridge/neurobridge#Scale
31-11	5216-5217	,	_
31-12	5218-5229	impulsivity	_
31-13	5230-5233	was	_
31-14	5234-5242	measured	_
31-15	5243-5245	by	_
31-16	5246-5249	the	_
31-17	5250-5257	Eysenck	http://maven.renci.org/NeuroBridge/neurobridge#EysenckImpulsivityScale
31-18	5258-5269	impulsivity	http://maven.renci.org/NeuroBridge/neurobridge#EysenckImpulsivityScale
31-19	5270-5275	scale	http://maven.renci.org/NeuroBridge/neurobridge#EysenckImpulsivityScale
31-20	5276-5277	,	_
31-21	5278-5281	and	_
31-22	5282-5292	antisocial	_
31-23	5293-5304	disposition	_
31-24	5305-5308	was	_
31-25	5309-5317	measured	_
31-26	5318-5320	by	_
31-27	5321-5324	the	_
31-28	5325-5329	MMPI	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
31-29	5330-5342	psychopathic	http://maven.renci.org/NeuroBridge/neurobridge#PsychopathologyScale
31-30	5343-5351	deviance	_
31-31	5352-5357	scale	http://maven.renci.org/NeuroBridge/neurobridge#Scale
31-32	5358-5359	.	_

Text=Group comparisons on clinical and psychological measures were examined using the General Linear Model within SPSS (SPSS Inc. 2009).
32-1	5360-5365	Group	_
32-2	5366-5377	comparisons	_
32-3	5378-5380	on	_
32-4	5381-5389	clinical	_
32-5	5390-5393	and	_
32-6	5394-5407	psychological	_
32-7	5408-5416	measures	_
32-8	5417-5421	were	_
32-9	5422-5430	examined	_
32-10	5431-5436	using	_
32-11	5437-5440	the	_
32-12	5441-5448	General	_
32-13	5449-5455	Linear	_
32-14	5456-5461	Model	_
32-15	5462-5468	within	_
32-16	5469-5473	SPSS	_
32-17	5474-5475	(	_
32-18	5476-5480	SPSS	_
32-19	5481-5485	Inc.	_
32-20	5486-5490	2009	_
32-21	5491-5492	)	_
32-22	5493-5494	.	_

Text=Measures of effect size are the odds ratios for rate data and partial η2 (proportion of variance of the dependent variable independently accounted for by group) for symptom counts, psychological measures and other demographic variables.
33-1	5495-5503	Measures	_
33-2	5504-5506	of	_
33-3	5507-5513	effect	_
33-4	5514-5518	size	_
33-5	5519-5522	are	_
33-6	5523-5526	the	_
33-7	5527-5531	odds	_
33-8	5532-5538	ratios	_
33-9	5539-5542	for	_
33-10	5543-5547	rate	_
33-11	5548-5552	data	_
33-12	5553-5556	and	_
33-13	5557-5564	partial	_
33-14	5565-5567	η2	_
33-15	5568-5569	(	_
33-16	5570-5580	proportion	_
33-17	5581-5583	of	_
33-18	5584-5592	variance	_
33-19	5593-5595	of	_
33-20	5596-5599	the	_
33-21	5600-5609	dependent	_
33-22	5610-5618	variable	_
33-23	5619-5632	independently	_
33-24	5633-5642	accounted	_
33-25	5643-5646	for	_
33-26	5647-5649	by	_
33-27	5650-5655	group	_
33-28	5656-5657	)	_
33-29	5658-5661	for	_
33-30	5662-5669	symptom	_
33-31	5670-5676	counts	_
33-32	5677-5678	,	_
33-33	5679-5692	psychological	_
33-34	5693-5701	measures	_
33-35	5702-5705	and	_
33-36	5706-5711	other	_
33-37	5712-5723	demographic	_
33-38	5724-5733	variables	_
33-39	5734-5735	.	_

Text=fMRI acquisition and processing Resting functional magnetic resonance (fMRI) data were collected using a twelve-channel head coil on a Siemens Tim Trio 3.0 T scanner (Siemens Medical Solutions, Erlangen Germany) located at Queen's Medical Center in Honolulu, using a protocol described in.
34-1	5736-5740	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
34-2	5741-5752	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
34-3	5753-5756	and	_
34-4	5757-5767	processing	_
34-5	5768-5775	Resting	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-6	5776-5786	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-7	5787-5795	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-8	5796-5805	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-9	5806-5807	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-10	5808-5812	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-11	5813-5814	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-12	5815-5819	data	_
34-13	5820-5824	were	_
34-14	5825-5834	collected	_
34-15	5835-5840	using	_
34-16	5841-5842	a	_
34-17	5843-5857	twelve-channel	_
34-18	5858-5862	head	_
34-19	5863-5867	coil	_
34-20	5868-5870	on	_
34-21	5871-5872	a	_
34-22	5873-5880	Siemens	_
34-23	5881-5884	Tim	_
34-24	5885-5889	Trio	_
34-25	5890-5893	3.0	_
34-26	5894-5895	T	_
34-27	5896-5903	scanner	_
34-28	5904-5905	(	_
34-29	5906-5913	Siemens	_
34-30	5914-5921	Medical	_
34-31	5922-5931	Solutions	_
34-32	5932-5933	,	_
34-33	5934-5942	Erlangen	_
34-34	5943-5950	Germany	_
34-35	5951-5952	)	_
34-36	5953-5960	located	_
34-37	5961-5963	at	_
34-38	5964-5969	Queen	_
34-39	5970-5972	's	_
34-40	5973-5980	Medical	_
34-41	5981-5987	Center	_
34-42	5988-5990	in	_
34-43	5991-5999	Honolulu	_
34-44	6000-6001	,	_
34-45	6002-6007	using	_
34-46	6008-6009	a	_
34-47	6010-6018	protocol	_
34-48	6019-6028	described	_
34-49	6029-6031	in	_
34-50	6032-6033	.	_

Text=All imaging data were preprocessed using the AFNI (Analysis of Functional NeuroImages and FMRIB Software Libraries (FSL; FMRIB, Oxford, United Kingdom), as detailed in.
35-1	6034-6037	All	_
35-2	6038-6045	imaging	_
35-3	6046-6050	data	_
35-4	6051-6055	were	_
35-5	6056-6068	preprocessed	_
35-6	6069-6074	using	_
35-7	6075-6078	the	_
35-8	6079-6083	AFNI	_
35-9	6084-6085	(	_
35-10	6086-6094	Analysis	_
35-11	6095-6097	of	_
35-12	6098-6108	Functional	_
35-13	6109-6120	NeuroImages	_
35-14	6121-6124	and	_
35-15	6125-6130	FMRIB	_
35-16	6131-6139	Software	_
35-17	6140-6149	Libraries	_
35-18	6150-6151	(	_
35-19	6152-6155	FSL	_
35-20	6156-6157	;	_
35-21	6158-6163	FMRIB	_
35-22	6164-6165	,	_
35-23	6166-6172	Oxford	_
35-24	6173-6174	,	_
35-25	6175-6181	United	_
35-26	6182-6189	Kingdom	_
35-27	6190-6191	)	_
35-28	6192-6193	,	_
35-29	6194-6196	as	_
35-30	6197-6205	detailed	_
35-31	6206-6208	in	_
35-32	6209-6210	.	_

Text=In summary, preprocessing consisted of: slice time correction; three-dimensional motion correction (using a 6 degree of freedom rigid registration with the first volume as reference); temporal despiking; spatial smoothing, mean-based intensity normalization; temporal bandpass filtering; and linear and quadratic detrending.
36-1	6211-6213	In	_
36-2	6214-6221	summary	_
36-3	6222-6223	,	_
36-4	6224-6237	preprocessing	_
36-5	6238-6247	consisted	_
36-6	6248-6250	of	_
36-7	6251-6252	:	_
36-8	6253-6258	slice	_
36-9	6259-6263	time	_
36-10	6264-6274	correction	_
36-11	6275-6276	;	_
36-12	6277-6294	three-dimensional	_
36-13	6295-6301	motion	_
36-14	6302-6312	correction	_
36-15	6313-6314	(	_
36-16	6315-6320	using	_
36-17	6321-6322	a	_
36-18	6323-6324	6	_
36-19	6325-6331	degree	_
36-20	6332-6334	of	_
36-21	6335-6342	freedom	_
36-22	6343-6348	rigid	_
36-23	6349-6361	registration	_
36-24	6362-6366	with	_
36-25	6367-6370	the	_
36-26	6371-6376	first	_
36-27	6377-6383	volume	_
36-28	6384-6386	as	_
36-29	6387-6396	reference	_
36-30	6397-6398	)	_
36-31	6399-6400	;	_
36-32	6401-6409	temporal	_
36-33	6410-6419	despiking	_
36-34	6420-6421	;	_
36-35	6422-6429	spatial	_
36-36	6430-6439	smoothing	_
36-37	6440-6441	,	_
36-38	6442-6452	mean-based	_
36-39	6453-6462	intensity	_
36-40	6463-6476	normalization	_
36-41	6477-6478	;	_
36-42	6479-6487	temporal	_
36-43	6488-6496	bandpass	_
36-44	6497-6506	filtering	_
36-45	6507-6508	;	_
36-46	6509-6512	and	_
36-47	6513-6519	linear	_
36-48	6520-6523	and	_
36-49	6524-6533	quadratic	_
36-50	6534-6544	detrending	_
36-51	6545-6546	.	_

Text=In addition, probabilistic independent component analysis was conducted for each individual to denoise individual data by removing components that represented motion, scanner artifacts, and physiological noise.
37-1	6547-6549	In	_
37-2	6550-6558	addition	_
37-3	6559-6560	,	_
37-4	6561-6574	probabilistic	_
37-5	6575-6586	independent	_
37-6	6587-6596	component	_
37-7	6597-6605	analysis	_
37-8	6606-6609	was	_
37-9	6610-6619	conducted	_
37-10	6620-6623	for	_
37-11	6624-6628	each	_
37-12	6629-6639	individual	_
37-13	6640-6642	to	_
37-14	6643-6650	denoise	_
37-15	6651-6661	individual	_
37-16	6662-6666	data	_
37-17	6667-6669	by	_
37-18	6670-6678	removing	_
37-19	6679-6689	components	_
37-20	6690-6694	that	_
37-21	6695-6706	represented	_
37-22	6707-6713	motion	_
37-23	6714-6715	,	_
37-24	6716-6723	scanner	_
37-25	6724-6733	artifacts	_
37-26	6734-6735	,	_
37-27	6736-6739	and	_
37-28	6740-6753	physiological	_
37-29	6754-6759	noise	_
37-30	6760-6761	.	_

Text=Noise components were selected by spatial and temporal characteristics detailed in the MELODIC (FSL) manual (http: //fmrib.ox.ac.uk/fslcourse/lectures/melodic.pdf) using selection criteria of noise components as described in.
38-1	6762-6767	Noise	_
38-2	6768-6778	components	_
38-3	6779-6783	were	_
38-4	6784-6792	selected	_
38-5	6793-6795	by	_
38-6	6796-6803	spatial	_
38-7	6804-6807	and	_
38-8	6808-6816	temporal	_
38-9	6817-6832	characteristics	_
38-10	6833-6841	detailed	_
38-11	6842-6844	in	_
38-12	6845-6848	the	_
38-13	6849-6856	MELODIC	_
38-14	6857-6858	(	_
38-15	6859-6862	FSL	_
38-16	6863-6864	)	_
38-17	6865-6871	manual	_
38-18	6872-6873	(	_
38-19	6874-6878	http	_
38-20	6879-6880	:	_
38-21	6881-6928	//fmrib.ox.ac.uk/fslcourse/lectures/melodic.pdf	_
38-22	6929-6930	)	_
38-23	6931-6936	using	_
38-24	6937-6946	selection	_
38-25	6947-6955	criteria	_
38-26	6956-6958	of	_
38-27	6959-6964	noise	_
38-28	6965-6975	components	_
38-29	6976-6978	as	_
38-30	6979-6988	described	_
38-31	6989-6991	in	_
38-32	6992-6993	.	_

Text=A between-groups t-test conducted to look for differences in the sum of total percent variance accounted for in components removed showed no significant group differences (t (1,44) = 0.89, p = 0.38).
39-1	6994-6995	A	_
39-2	6996-7010	between-groups	_
39-3	7011-7017	t-test	_
39-4	7018-7027	conducted	_
39-5	7028-7030	to	_
39-6	7031-7035	look	_
39-7	7036-7039	for	_
39-8	7040-7051	differences	_
39-9	7052-7054	in	_
39-10	7055-7058	the	_
39-11	7059-7062	sum	_
39-12	7063-7065	of	_
39-13	7066-7071	total	_
39-14	7072-7079	percent	_
39-15	7080-7088	variance	_
39-16	7089-7098	accounted	_
39-17	7099-7102	for	_
39-18	7103-7105	in	_
39-19	7106-7116	components	_
39-20	7117-7124	removed	_
39-21	7125-7131	showed	_
39-22	7132-7134	no	_
39-23	7135-7146	significant	_
39-24	7147-7152	group	_
39-25	7153-7164	differences	_
39-26	7165-7166	(	_
39-27	7167-7168	t	_
39-28	7169-7170	(	_
39-29	7171-7175	1,44	_
39-30	7176-7177	)	_
39-31	7178-7179	=	_
39-32	7180-7184	0.89	_
39-33	7185-7186	,	_
39-34	7187-7188	p	_
39-35	7189-7190	=	_
39-36	7191-7195	0.38	_
39-37	7196-7197	)	_
39-38	7198-7199	.	_

Text=Preprocessed resting state images were also registered to the MNI152 atlas for further analysis and seed placement.
40-1	7200-7212	Preprocessed	_
40-2	7213-7220	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-3	7221-7226	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-4	7227-7233	images	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-5	7234-7238	were	_
40-6	7239-7243	also	_
40-7	7244-7254	registered	_
40-8	7255-7257	to	_
40-9	7258-7261	the	_
40-10	7262-7268	MNI152	_
40-11	7269-7274	atlas	_
40-12	7275-7278	for	_
40-13	7279-7286	further	_
40-14	7287-7295	analysis	_
40-15	7296-7299	and	_
40-16	7300-7304	seed	_
40-17	7305-7314	placement	_
40-18	7315-7316	.	_

Text=To examine networks involved in the maintenance of abstinence from alcohol, spherical seeds with 3.5 mm radii were placed at left and right nucleus accumbens (NAcc) based on the Talaraich Daemon atlas from AFNI (MNI coordinates: x = ± 12, y = 10, z = − 1).
41-1	7317-7319	To	_
41-2	7320-7327	examine	_
41-3	7328-7336	networks	_
41-4	7337-7345	involved	_
41-5	7346-7348	in	_
41-6	7349-7352	the	_
41-7	7353-7364	maintenance	_
41-8	7365-7367	of	_
41-9	7368-7378	abstinence	_
41-10	7379-7383	from	_
41-11	7384-7391	alcohol	_
41-12	7392-7393	,	_
41-13	7394-7403	spherical	_
41-14	7404-7409	seeds	_
41-15	7410-7414	with	_
41-16	7415-7418	3.5	_
41-17	7419-7421	mm	_
41-18	7422-7427	radii	_
41-19	7428-7432	were	_
41-20	7433-7439	placed	_
41-21	7440-7442	at	_
41-22	7443-7447	left	_
41-23	7448-7451	and	_
41-24	7452-7457	right	_
41-25	7458-7465	nucleus	_
41-26	7466-7475	accumbens	_
41-27	7476-7477	(	_
41-28	7478-7482	NAcc	_
41-29	7483-7484	)	_
41-30	7485-7490	based	_
41-31	7491-7493	on	_
41-32	7494-7497	the	_
41-33	7498-7507	Talaraich	_
41-34	7508-7514	Daemon	_
41-35	7515-7520	atlas	_
41-36	7521-7525	from	_
41-37	7526-7530	AFNI	_
41-38	7531-7532	(	_
41-39	7533-7536	MNI	_
41-40	7537-7548	coordinates	_
41-41	7549-7550	:	_
41-42	7551-7552	x	_
41-43	7553-7554	=	_
41-44	7555-7556	±	_
41-45	7557-7559	12	_
41-46	7560-7561	,	_
41-47	7562-7563	y	_
41-48	7564-7565	=	_
41-49	7566-7568	10	_
41-50	7569-7570	,	_
41-51	7571-7572	z	_
41-52	7573-7574	=	_
41-53	7575-7576	−	_
41-54	7577-7578	1	_
41-55	7579-7580	)	_
41-56	7581-7582	.	_

Text=As described in, we originally examined left and right NAcc separately, but because results were highly similar (r = 0.81, p = 7.47 × 10− 12), they were combined.
42-1	7583-7585	As	_
42-2	7586-7595	described	_
42-3	7596-7598	in	_
42-4	7599-7600	,	_
42-5	7601-7603	we	_
42-6	7604-7614	originally	_
42-7	7615-7623	examined	_
42-8	7624-7628	left	_
42-9	7629-7632	and	_
42-10	7633-7638	right	_
42-11	7639-7643	NAcc	_
42-12	7644-7654	separately	_
42-13	7655-7656	,	_
42-14	7657-7660	but	_
42-15	7661-7668	because	_
42-16	7669-7676	results	_
42-17	7677-7681	were	_
42-18	7682-7688	highly	_
42-19	7689-7696	similar	_
42-20	7697-7698	(	_
42-21	7699-7700	r	_
42-22	7701-7702	=	_
42-23	7703-7707	0.81	_
42-24	7708-7709	,	_
42-25	7710-7711	p	_
42-26	7712-7713	=	_
42-27	7714-7718	7.47	_
42-28	7719-7720	×	_
42-29	7721-7724	10−	_
42-30	7725-7727	12	_
42-31	7728-7729	)	_
42-32	7730-7731	,	_
42-33	7732-7736	they	_
42-34	7737-7741	were	_
42-35	7742-7750	combined	_
42-36	7751-7752	.	_

Text=For each participant, a multiple regression analysis (FSL-FEAT, see) on the denoised data was performed.
43-1	7753-7756	For	_
43-2	7757-7761	each	_
43-3	7762-7773	participant	_
43-4	7774-7775	,	_
43-5	7776-7777	a	_
43-6	7778-7786	multiple	_
43-7	7787-7797	regression	_
43-8	7798-7806	analysis	_
43-9	7807-7808	(	_
43-10	7809-7817	FSL-FEAT	_
43-11	7818-7819	,	_
43-12	7820-7823	see	_
43-13	7824-7825	)	_
43-14	7826-7828	on	_
43-15	7829-7832	the	_
43-16	7833-7841	denoised	_
43-17	7842-7846	data	_
43-18	7847-7850	was	_
43-19	7851-7860	performed	_
43-20	7861-7862	.	_

Text=This analysis generated a map of statistical parameter estimates for each voxel, for each individual.
44-1	7863-7867	This	_
44-2	7868-7876	analysis	_
44-3	7877-7886	generated	_
44-4	7887-7888	a	_
44-5	7889-7892	map	_
44-6	7893-7895	of	_
44-7	7896-7907	statistical	_
44-8	7908-7917	parameter	_
44-9	7918-7927	estimates	_
44-10	7928-7931	for	_
44-11	7932-7936	each	_
44-12	7937-7942	voxel	_
44-13	7943-7944	,	_
44-14	7945-7948	for	_
44-15	7949-7953	each	_
44-16	7954-7964	individual	_
44-17	7965-7966	.	_

Text=All voxels in the maps showed the degree of positive or negative correlations with the average time-series (over the left and right NAcc seeds) for each participant.
45-1	7967-7970	All	_
45-2	7971-7977	voxels	_
45-3	7978-7980	in	_
45-4	7981-7984	the	_
45-5	7985-7989	maps	_
45-6	7990-7996	showed	_
45-7	7997-8000	the	_
45-8	8001-8007	degree	_
45-9	8008-8010	of	_
45-10	8011-8019	positive	_
45-11	8020-8022	or	_
45-12	8023-8031	negative	_
45-13	8032-8044	correlations	_
45-14	8045-8049	with	_
45-15	8050-8053	the	_
45-16	8054-8061	average	_
45-17	8062-8073	time-series	_
45-18	8074-8075	(	_
45-19	8076-8080	over	_
45-20	8081-8084	the	_
45-21	8085-8089	left	_
45-22	8090-8093	and	_
45-23	8094-8099	right	_
45-24	8100-8104	NAcc	_
45-25	8105-8110	seeds	_
45-26	8111-8112	)	_
45-27	8113-8116	for	_
45-28	8117-8121	each	_
45-29	8122-8133	participant	_
45-30	8134-8135	.	_

Text=Correlation values at each voxel were transformed to z-scores.
46-1	8136-8147	Correlation	_
46-2	8148-8154	values	_
46-3	8155-8157	at	_
46-4	8158-8162	each	_
46-5	8163-8168	voxel	_
46-6	8169-8173	were	_
46-7	8174-8185	transformed	_
46-8	8186-8188	to	_
46-9	8189-8197	z-scores	_
46-10	8198-8199	.	_

Text=In our previous work, dorsolateral prefrontal cortex (DLPFC) regions of the executive control network showed greater RSS with NAcc; thalamic nuclei (anterior and medial dorsal) and inferior parietal regions of the appetitive drive network showed lesser RSS with NAcc in LTAA compared to controls.
47-1	8200-8202	In	_
47-2	8203-8206	our	_
47-3	8207-8215	previous	_
47-4	8216-8220	work	_
47-5	8221-8222	,	_
47-6	8223-8235	dorsolateral	_
47-7	8236-8246	prefrontal	_
47-8	8247-8253	cortex	_
47-9	8254-8255	(	_
47-10	8256-8261	DLPFC	_
47-11	8262-8263	)	_
47-12	8264-8271	regions	_
47-13	8272-8274	of	_
47-14	8275-8278	the	_
47-15	8279-8288	executive	_
47-16	8289-8296	control	_
47-17	8297-8304	network	_
47-18	8305-8311	showed	_
47-19	8312-8319	greater	_
47-20	8320-8323	RSS	_
47-21	8324-8328	with	_
47-22	8329-8333	NAcc	_
47-23	8334-8335	;	_
47-24	8336-8344	thalamic	_
47-25	8345-8351	nuclei	_
47-26	8352-8353	(	_
47-27	8354-8362	anterior	_
47-28	8363-8366	and	_
47-29	8367-8373	medial	_
47-30	8374-8380	dorsal	_
47-31	8381-8382	)	_
47-32	8383-8386	and	_
47-33	8387-8395	inferior	_
47-34	8396-8404	parietal	_
47-35	8405-8412	regions	_
47-36	8413-8415	of	_
47-37	8416-8419	the	_
47-38	8420-8430	appetitive	_
47-39	8431-8436	drive	_
47-40	8437-8444	network	_
47-41	8445-8451	showed	_
47-42	8452-8458	lesser	_
47-43	8459-8462	RSS	_
47-44	8463-8467	with	_
47-45	8468-8472	NAcc	_
47-46	8473-8475	in	_
47-47	8476-8480	LTAA	_
47-48	8481-8489	compared	_
47-49	8490-8492	to	_
47-50	8493-8501	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
47-51	8502-8503	.	_

Text=EEG acquisition and processing We recorded 64-channel resting eyes-open EEGs using the SynAmps2 amplifier and Scan 4.3 acquisition software (Compumedics Neuroscan Inc., Charlotte NC).
48-1	8504-8507	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
48-2	8508-8519	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
48-3	8520-8523	and	_
48-4	8524-8534	processing	_
48-5	8535-8537	We	_
48-6	8538-8546	recorded	_
48-7	8547-8557	64-channel	_
48-8	8558-8565	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
48-9	8566-8575	eyes-open	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
48-10	8576-8580	EEGs	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
48-11	8581-8586	using	_
48-12	8587-8590	the	_
48-13	8591-8599	SynAmps2	_
48-14	8600-8609	amplifier	_
48-15	8610-8613	and	_
48-16	8614-8618	Scan	_
48-17	8619-8622	4.3	_
48-18	8623-8634	acquisition	_
48-19	8635-8643	software	_
48-20	8644-8645	(	_
48-21	8646-8657	Compumedics	_
48-22	8658-8667	Neuroscan	_
48-23	8668-8672	Inc.	_
48-24	8673-8674	,	_
48-25	8675-8684	Charlotte	_
48-26	8685-8687	NC	_
48-27	8688-8689	)	_
48-28	8690-8691	.	_

Text=The EEG signal was referenced to an electrode between Cz and CPz for online recording, and then re-referenced to the right ear offline.
49-1	8692-8695	The	_
49-2	8696-8699	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
49-3	8700-8706	signal	_
49-4	8707-8710	was	_
49-5	8711-8721	referenced	_
49-6	8722-8724	to	_
49-7	8725-8727	an	_
49-8	8728-8737	electrode	_
49-9	8738-8745	between	_
49-10	8746-8748	Cz	_
49-11	8749-8752	and	_
49-12	8753-8756	CPz	_
49-13	8757-8760	for	_
49-14	8761-8767	online	_
49-15	8768-8777	recording	_
49-16	8778-8779	,	_
49-17	8780-8783	and	_
49-18	8784-8788	then	_
49-19	8789-8802	re-referenced	_
49-20	8803-8805	to	_
49-21	8806-8809	the	_
49-22	8810-8815	right	_
49-23	8816-8819	ear	_
49-24	8820-8827	offline	_
49-25	8828-8829	.	_

Text=The ground electrode was placed 8 cm above the nasion.
50-1	8830-8833	The	_
50-2	8834-8840	ground	_
50-3	8841-8850	electrode	_
50-4	8851-8854	was	_
50-5	8855-8861	placed	_
50-6	8862-8863	8	_
50-7	8864-8866	cm	_
50-8	8867-8872	above	_
50-9	8873-8876	the	_
50-10	8877-8883	nasion	_
50-11	8884-8885	.	_

Text=Electrode impedances were maintained below 10 kΩ.
51-1	8886-8895	Electrode	_
51-2	8896-8906	impedances	_
51-3	8907-8911	were	_
51-4	8912-8922	maintained	_
51-5	8923-8928	below	_
51-6	8929-8931	10	_
51-7	8932-8934	kΩ	_
51-8	8935-8936	.	_

Text=The sampling rate was 250 Hz, analog filters were 0.3–70 Hz, and 7–8 min of data were recorded.
52-1	8937-8940	The	_
52-2	8941-8949	sampling	_
52-3	8950-8954	rate	_
52-4	8955-8958	was	_
52-5	8959-8962	250	_
52-6	8963-8965	Hz	_
52-7	8966-8967	,	_
52-8	8968-8974	analog	_
52-9	8975-8982	filters	_
52-10	8983-8987	were	_
52-11	8988-8994	0.3–70	_
52-12	8995-8997	Hz	_
52-13	8998-8999	,	_
52-14	9000-9003	and	_
52-15	9004-9007	7–8	_
52-16	9008-9011	min	_
52-17	9012-9014	of	_
52-18	9015-9019	data	_
52-19	9020-9024	were	_
52-20	9025-9033	recorded	_
52-21	9034-9035	.	_

Text=EEG recordings were processed offline using the Edit program in Scan 4.3.
53-1	9036-9039	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
53-2	9040-9050	recordings	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
53-3	9051-9055	were	_
53-4	9056-9065	processed	_
53-5	9066-9073	offline	_
53-6	9074-9079	using	_
53-7	9080-9083	the	_
53-8	9084-9088	Edit	_
53-9	9089-9096	program	_
53-10	9097-9099	in	_
53-11	9100-9104	Scan	_
53-12	9105-9108	4.3	_
53-13	9109-9110	.	_

Text=Artifacts from eye movements were removed using the ocular artifact reduction algorithm (ARTCOR procedure) in Scan 4.3.
54-1	9111-9120	Artifacts	_
54-2	9121-9125	from	_
54-3	9126-9129	eye	_
54-4	9130-9139	movements	_
54-5	9140-9144	were	_
54-6	9145-9152	removed	_
54-7	9153-9158	using	_
54-8	9159-9162	the	_
54-9	9163-9169	ocular	_
54-10	9170-9178	artifact	_
54-11	9179-9188	reduction	_
54-12	9189-9198	algorithm	_
54-13	9199-9200	(	_
54-14	9201-9207	ARTCOR	_
54-15	9208-9217	procedure	_
54-16	9218-9219	)	_
54-17	9220-9222	in	_
54-18	9223-9227	Scan	_
54-19	9228-9231	4.3	_
54-20	9232-9233	.	_

Text=The resulting EEG was unusable for three LTAA participants and two NSAC participants due to excessive noise and voltages out of range.
55-1	9234-9237	The	_
55-2	9238-9247	resulting	_
55-3	9248-9251	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
55-4	9252-9255	was	_
55-5	9256-9264	unusable	_
55-6	9265-9268	for	_
55-7	9269-9274	three	_
55-8	9275-9279	LTAA	http://maven.renci.org/NeuroBridge/neurobridge#DataAnalysisMethod
55-9	9280-9292	participants	_
55-10	9293-9296	and	_
55-11	9297-9300	two	_
55-12	9301-9305	NSAC	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale
55-13	9306-9318	participants	_
55-14	9319-9322	due	_
55-15	9323-9325	to	_
55-16	9326-9335	excessive	_
55-17	9336-9341	noise	_
55-18	9342-9345	and	_
55-19	9346-9354	voltages	_
55-20	9355-9358	out	_
55-21	9359-9361	of	_
55-22	9362-9367	range	_
55-23	9368-9369	.	_

Text=Coherence between all pairs of channels was computed as follows: 1) the first 20 s of each recording was discarded, to allow electrode impedances to settle, 2) the magnitude squared coherence was estimated over the next 4 min of data using Welch's averaged, modified periodogram method, using 2 s epochs with 50% overlap, 3) coherence estimates were then averaged within frequency bands for delta (1–3 Hz), theta (4–7 Hz), alpha1 (8–9 Hz), alpha2 (10–12 Hz), beta1 (13–17 Hz), beta2 (18–30 Hz), gamma1 (31–40 Hz), and gamma2 (41–50 Hz).
56-1	9370-9379	Coherence	_
56-2	9380-9387	between	_
56-3	9388-9391	all	_
56-4	9392-9397	pairs	_
56-5	9398-9400	of	_
56-6	9401-9409	channels	_
56-7	9410-9413	was	_
56-8	9414-9422	computed	_
56-9	9423-9425	as	_
56-10	9426-9433	follows	_
56-11	9434-9435	:	_
56-12	9436-9437	1	_
56-13	9438-9439	)	_
56-14	9440-9443	the	_
56-15	9444-9449	first	_
56-16	9450-9452	20	_
56-17	9453-9454	s	_
56-18	9455-9457	of	_
56-19	9458-9462	each	_
56-20	9463-9472	recording	_
56-21	9473-9476	was	_
56-22	9477-9486	discarded	_
56-23	9487-9488	,	_
56-24	9489-9491	to	_
56-25	9492-9497	allow	_
56-26	9498-9507	electrode	_
56-27	9508-9518	impedances	_
56-28	9519-9521	to	_
56-29	9522-9528	settle	_
56-30	9529-9530	,	_
56-31	9531-9532	2	_
56-32	9533-9534	)	_
56-33	9535-9538	the	_
56-34	9539-9548	magnitude	_
56-35	9549-9556	squared	_
56-36	9557-9566	coherence	_
56-37	9567-9570	was	_
56-38	9571-9580	estimated	_
56-39	9581-9585	over	_
56-40	9586-9589	the	_
56-41	9590-9594	next	_
56-42	9595-9596	4	_
56-43	9597-9600	min	_
56-44	9601-9603	of	_
56-45	9604-9608	data	_
56-46	9609-9614	using	_
56-47	9615-9620	Welch	_
56-48	9621-9623	's	_
56-49	9624-9632	averaged	_
56-50	9633-9634	,	_
56-51	9635-9643	modified	_
56-52	9644-9655	periodogram	_
56-53	9656-9662	method	_
56-54	9663-9664	,	_
56-55	9665-9670	using	_
56-56	9671-9672	2	_
56-57	9673-9674	s	_
56-58	9675-9681	epochs	_
56-59	9682-9686	with	_
56-60	9687-9689	50	_
56-61	9690-9691	%	_
56-62	9692-9699	overlap	_
56-63	9700-9701	,	_
56-64	9702-9703	3	_
56-65	9704-9705	)	_
56-66	9706-9715	coherence	_
56-67	9716-9725	estimates	_
56-68	9726-9730	were	_
56-69	9731-9735	then	_
56-70	9736-9744	averaged	_
56-71	9745-9751	within	_
56-72	9752-9761	frequency	_
56-73	9762-9767	bands	_
56-74	9768-9771	for	_
56-75	9772-9777	delta	_
56-76	9778-9779	(	_
56-77	9780-9783	1–3	_
56-78	9784-9786	Hz	_
56-79	9787-9788	)	_
56-80	9789-9790	,	_
56-81	9791-9796	theta	_
56-82	9797-9798	(	_
56-83	9799-9802	4–7	_
56-84	9803-9805	Hz	_
56-85	9806-9807	)	_
56-86	9808-9809	,	_
56-87	9810-9816	alpha1	_
56-88	9817-9818	(	_
56-89	9819-9822	8–9	_
56-90	9823-9825	Hz	_
56-91	9826-9827	)	_
56-92	9828-9829	,	_
56-93	9830-9836	alpha2	_
56-94	9837-9838	(	_
56-95	9839-9844	10–12	_
56-96	9845-9847	Hz	_
56-97	9848-9849	)	_
56-98	9850-9851	,	_
56-99	9852-9857	beta1	_
56-100	9858-9859	(	_
56-101	9860-9865	13–17	_
56-102	9866-9868	Hz	_
56-103	9869-9870	)	_
56-104	9871-9872	,	_
56-105	9873-9878	beta2	_
56-106	9879-9880	(	_
56-107	9881-9886	18–30	_
56-108	9887-9889	Hz	_
56-109	9890-9891	)	_
56-110	9892-9893	,	_
56-111	9894-9900	gamma1	_
56-112	9901-9902	(	_
56-113	9903-9908	31–40	_
56-114	9909-9911	Hz	_
56-115	9912-9913	)	_
56-116	9914-9915	,	_
56-117	9916-9919	and	_
56-118	9920-9926	gamma2	_
56-119	9927-9928	(	_
56-120	9929-9934	41–50	_
56-121	9935-9937	Hz	_
56-122	9938-9939	)	_
56-123	9940-9941	.	_

Text=EEG theta, alpha, and beta have been previously studied in neurofeedback treatments and have been shown to alter EEG resting state networks following alcohol consumption.
57-1	9942-9945	EEG	_
57-2	9946-9951	theta	_
57-3	9952-9953	,	_
57-4	9954-9959	alpha	_
57-5	9960-9961	,	_
57-6	9962-9965	and	_
57-7	9966-9970	beta	_
57-8	9971-9975	have	_
57-9	9976-9980	been	_
57-10	9981-9991	previously	_
57-11	9992-9999	studied	_
57-12	10000-10002	in	_
57-13	10003-10016	neurofeedback	_
57-14	10017-10027	treatments	_
57-15	10028-10031	and	_
57-16	10032-10036	have	_
57-17	10037-10041	been	_
57-18	10042-10047	shown	_
57-19	10048-10050	to	_
57-20	10051-10056	alter	_
57-21	10057-10060	EEG	_
57-22	10061-10068	resting	_
57-23	10069-10074	state	_
57-24	10075-10083	networks	_
57-25	10084-10093	following	_
57-26	10094-10101	alcohol	_
57-27	10102-10113	consumption	_
57-28	10114-10115	.	_

Text=fMRI BOLD signals are thought to arise from the summed neural activities of several oscillatory EEG networks, particularly gamma.
58-1	10116-10120	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
58-2	10121-10125	BOLD	_
58-3	10126-10133	signals	_
58-4	10134-10137	are	_
58-5	10138-10145	thought	_
58-6	10146-10148	to	_
58-7	10149-10154	arise	_
58-8	10155-10159	from	_
58-9	10160-10163	the	_
58-10	10164-10170	summed	_
58-11	10171-10177	neural	_
58-12	10178-10188	activities	_
58-13	10189-10191	of	_
58-14	10192-10199	several	_
58-15	10200-10211	oscillatory	_
58-16	10212-10215	EEG	_
58-17	10216-10224	networks	_
58-18	10225-10226	,	_
58-19	10227-10239	particularly	_
58-20	10240-10245	gamma	_
58-21	10246-10247	.	_

Text=Therefore, in this paper we focused on theta, alpha, beta, and gamma bands.
59-1	10248-10257	Therefore	_
59-2	10258-10259	,	_
59-3	10260-10262	in	_
59-4	10263-10267	this	_
59-5	10268-10273	paper	_
59-6	10274-10276	we	_
59-7	10277-10284	focused	_
59-8	10285-10287	on	_
59-9	10288-10293	theta	_
59-10	10294-10295	,	_
59-11	10296-10301	alpha	_
59-12	10302-10303	,	_
59-13	10304-10308	beta	_
59-14	10309-10310	,	_
59-15	10311-10314	and	_
59-16	10315-10320	gamma	_
59-17	10321-10326	bands	_
59-18	10327-10328	.	_

Text=For these bands, the upper-half of the resulting coherence matrix (excluding the diagonal) was rearranged into a single vector of length 2016 ((64 electrodes × 64 electrodes − 64) /2).
60-1	10329-10332	For	_
60-2	10333-10338	these	_
60-3	10339-10344	bands	_
60-4	10345-10346	,	_
60-5	10347-10350	the	_
60-6	10351-10361	upper-half	_
60-7	10362-10364	of	_
60-8	10365-10368	the	_
60-9	10369-10378	resulting	_
60-10	10379-10388	coherence	_
60-11	10389-10395	matrix	_
60-12	10396-10397	(	_
60-13	10398-10407	excluding	_
60-14	10408-10411	the	_
60-15	10412-10420	diagonal	_
60-16	10421-10422	)	_
60-17	10423-10426	was	_
60-18	10427-10437	rearranged	_
60-19	10438-10442	into	_
60-20	10443-10444	a	_
60-21	10445-10451	single	_
60-22	10452-10458	vector	_
60-23	10459-10461	of	_
60-24	10462-10468	length	_
60-25	10469-10473	2016	_
60-26	10474-10475	(	_
60-27	10476-10477	(	_
60-28	10478-10480	64	_
60-29	10481-10491	electrodes	_
60-30	10492-10493	×	_
60-31	10494-10496	64	_
60-32	10497-10507	electrodes	_
60-33	10508-10509	−	_
60-34	10510-10512	64	_
60-35	10513-10514	)	_
60-36	10515-10517	/2	_
60-37	10518-10519	)	_
60-38	10520-10521	.	_

Text=Coherence vectors for the seven frequency bands of interest were concatenated to form one vector of length 14,112 reflecting coherence in the desired bands between all electrodes for input to parallel ICA.
61-1	10522-10531	Coherence	_
61-2	10532-10539	vectors	_
61-3	10540-10543	for	_
61-4	10544-10547	the	_
61-5	10548-10553	seven	_
61-6	10554-10563	frequency	_
61-7	10564-10569	bands	_
61-8	10570-10572	of	_
61-9	10573-10581	interest	_
61-10	10582-10586	were	_
61-11	10587-10599	concatenated	_
61-12	10600-10602	to	_
61-13	10603-10607	form	_
61-14	10608-10611	one	_
61-15	10612-10618	vector	_
61-16	10619-10621	of	_
61-17	10622-10628	length	_
61-18	10629-10635	14,112	_
61-19	10636-10646	reflecting	_
61-20	10647-10656	coherence	_
61-21	10657-10659	in	_
61-22	10660-10663	the	_
61-23	10664-10671	desired	_
61-24	10672-10677	bands	_
61-25	10678-10685	between	_
61-26	10686-10689	all	_
61-27	10690-10700	electrodes	_
61-28	10701-10704	for	_
61-29	10705-10710	input	_
61-30	10711-10713	to	_
61-31	10714-10722	parallel	_
61-32	10723-10726	ICA	_
61-33	10727-10728	.	_

Text=Parallel ICA We analyzed rs-fMRI whole-brain seed-correlation maps and the vector of EEG-coherence jointly, taking all image voxels and coherence values into account simultaneously using parallel ICA (Fusion ICA Toolbox:).
62-1	10729-10737	Parallel	_
62-2	10738-10741	ICA	_
62-3	10742-10744	We	_
62-4	10745-10753	analyzed	_
62-5	10754-10761	rs-fMRI	_
62-6	10762-10773	whole-brain	_
62-7	10774-10790	seed-correlation	_
62-8	10791-10795	maps	_
62-9	10796-10799	and	_
62-10	10800-10803	the	_
62-11	10804-10810	vector	_
62-12	10811-10813	of	_
62-13	10814-10827	EEG-coherence	_
62-14	10828-10835	jointly	_
62-15	10836-10837	,	_
62-16	10838-10844	taking	_
62-17	10845-10848	all	_
62-18	10849-10854	image	_
62-19	10855-10861	voxels	_
62-20	10862-10865	and	_
62-21	10866-10875	coherence	_
62-22	10876-10882	values	_
62-23	10883-10887	into	_
62-24	10888-10895	account	_
62-25	10896-10910	simultaneously	_
62-26	10911-10916	using	_
62-27	10917-10925	parallel	_
62-28	10926-10929	ICA	_
62-29	10930-10931	(	_
62-30	10932-10938	Fusion	_
62-31	10939-10942	ICA	_
62-32	10943-10950	Toolbox	_
62-33	10951-10952	:	_
62-34	10953-10954	)	_
62-35	10955-10956	.	_

Text=Parallel ICA is described in detail in.
63-1	10957-10965	Parallel	_
63-2	10966-10969	ICA	_
63-3	10970-10972	is	_
63-4	10973-10982	described	_
63-5	10983-10985	in	_
63-6	10986-10992	detail	_
63-7	10993-10995	in	_
63-8	10996-10997	.	_

Text=Parallel ICA aims to identify independent components from the seed-correlation map and the EEG-coherence vector in addition to the relationship between them.
64-1	10998-11006	Parallel	_
64-2	11007-11010	ICA	_
64-3	11011-11015	aims	_
64-4	11016-11018	to	_
64-5	11019-11027	identify	_
64-6	11028-11039	independent	_
64-7	11040-11050	components	_
64-8	11051-11055	from	_
64-9	11056-11059	the	_
64-10	11060-11076	seed-correlation	_
64-11	11077-11080	map	_
64-12	11081-11084	and	_
64-13	11085-11088	the	_
64-14	11089-11102	EEG-coherence	_
64-15	11103-11109	vector	_
64-16	11110-11112	in	_
64-17	11113-11121	addition	_
64-18	11122-11124	to	_
64-19	11125-11128	the	_
64-20	11129-11141	relationship	_
64-21	11142-11149	between	_
64-22	11150-11154	them	_
64-23	11155-11156	.	_

Text=Components extracted from the seed-correlation map can be interpreted as networks of brain regions with spatially similar seed-synchrony across subjects, but the strength of synchrony within each network may differ across subjects.
65-1	11157-11167	Components	_
65-2	11168-11177	extracted	_
65-3	11178-11182	from	_
65-4	11183-11186	the	_
65-5	11187-11203	seed-correlation	_
65-6	11204-11207	map	_
65-7	11208-11211	can	_
65-8	11212-11214	be	_
65-9	11215-11226	interpreted	_
65-10	11227-11229	as	_
65-11	11230-11238	networks	_
65-12	11239-11241	of	_
65-13	11242-11247	brain	_
65-14	11248-11255	regions	_
65-15	11256-11260	with	_
65-16	11261-11270	spatially	_
65-17	11271-11278	similar	_
65-18	11279-11293	seed-synchrony	_
65-19	11294-11300	across	_
65-20	11301-11309	subjects	_
65-21	11310-11311	,	_
65-22	11312-11315	but	_
65-23	11316-11319	the	_
65-24	11320-11328	strength	_
65-25	11329-11331	of	_
65-26	11332-11341	synchrony	_
65-27	11342-11348	within	_
65-28	11349-11353	each	_
65-29	11354-11361	network	_
65-30	11362-11365	may	_
65-31	11366-11372	differ	_
65-32	11373-11379	across	_
65-33	11380-11388	subjects	_
65-34	11389-11390	.	_

Text=Components extracted from the scalp-recorded EEG-coherence reflect frequency-specific EEG oscillations within networks, which are also expressed to different degrees across subjects.
66-1	11391-11401	Components	_
66-2	11402-11411	extracted	_
66-3	11412-11416	from	_
66-4	11417-11420	the	_
66-5	11421-11435	scalp-recorded	_
66-6	11436-11449	EEG-coherence	_
66-7	11450-11457	reflect	_
66-8	11458-11476	frequency-specific	_
66-9	11477-11480	EEG	_
66-10	11481-11493	oscillations	_
66-11	11494-11500	within	_
66-12	11501-11509	networks	_
66-13	11510-11511	,	_
66-14	11512-11517	which	_
66-15	11518-11521	are	_
66-16	11522-11526	also	_
66-17	11527-11536	expressed	_
66-18	11537-11539	to	_
66-19	11540-11549	different	_
66-20	11550-11557	degrees	_
66-21	11558-11564	across	_
66-22	11565-11573	subjects	_
66-23	11574-11575	.	_

Text=Extracted components are not sparse; components extracted from the seed-correlation map will have a contribution from every voxel in the map, and components extracted from the EEG-coherence will have a contribution from every electrode pair within every frequency band.
67-1	11576-11585	Extracted	_
67-2	11586-11596	components	_
67-3	11597-11600	are	_
67-4	11601-11604	not	_
67-5	11605-11611	sparse	_
67-6	11612-11613	;	_
67-7	11614-11624	components	_
67-8	11625-11634	extracted	_
67-9	11635-11639	from	_
67-10	11640-11643	the	_
67-11	11644-11660	seed-correlation	_
67-12	11661-11664	map	_
67-13	11665-11669	will	_
67-14	11670-11674	have	_
67-15	11675-11676	a	_
67-16	11677-11689	contribution	_
67-17	11690-11694	from	_
67-18	11695-11700	every	_
67-19	11701-11706	voxel	_
67-20	11707-11709	in	_
67-21	11710-11713	the	_
67-22	11714-11717	map	_
67-23	11718-11719	,	_
67-24	11720-11723	and	_
67-25	11724-11734	components	_
67-26	11735-11744	extracted	_
67-27	11745-11749	from	_
67-28	11750-11753	the	_
67-29	11754-11767	EEG-coherence	_
67-30	11768-11772	will	_
67-31	11773-11777	have	_
67-32	11778-11779	a	_
67-33	11780-11792	contribution	_
67-34	11793-11797	from	_
67-35	11798-11803	every	_
67-36	11804-11813	electrode	_
67-37	11814-11818	pair	_
67-38	11819-11825	within	_
67-39	11826-11831	every	_
67-40	11832-11841	frequency	_
67-41	11842-11846	band	_
67-42	11847-11848	.	_

Text=The loading parameters for each component reflect the contribution of each network to that subject's whole brain seed-correlation map or EEG-coherence.
68-1	11849-11852	The	_
68-2	11853-11860	loading	_
68-3	11861-11871	parameters	_
68-4	11872-11875	for	_
68-5	11876-11880	each	_
68-6	11881-11890	component	_
68-7	11891-11898	reflect	_
68-8	11899-11902	the	_
68-9	11903-11915	contribution	_
68-10	11916-11918	of	_
68-11	11919-11923	each	_
68-12	11924-11931	network	_
68-13	11932-11934	to	_
68-14	11935-11939	that	_
68-15	11940-11947	subject	_
68-16	11948-11950	's	_
68-17	11951-11956	whole	_
68-18	11957-11962	brain	_
68-19	11963-11979	seed-correlation	_
68-20	11980-11983	map	_
68-21	11984-11986	or	_
68-22	11987-12000	EEG-coherence	_
68-23	12001-12002	.	_

Text=Parallel ICA also models the relationship between the components estimated from each modality, such that the loading parameters between an estimated EEG-coherence component and a seed-correlation map component are correlated across all participants if they reflect the same underlying network.
69-1	12003-12011	Parallel	_
69-2	12012-12015	ICA	_
69-3	12016-12020	also	_
69-4	12021-12027	models	_
69-5	12028-12031	the	_
69-6	12032-12044	relationship	_
69-7	12045-12052	between	_
69-8	12053-12056	the	_
69-9	12057-12067	components	_
69-10	12068-12077	estimated	_
69-11	12078-12082	from	_
69-12	12083-12087	each	_
69-13	12088-12096	modality	_
69-14	12097-12098	,	_
69-15	12099-12103	such	_
69-16	12104-12108	that	_
69-17	12109-12112	the	_
69-18	12113-12120	loading	_
69-19	12121-12131	parameters	_
69-20	12132-12139	between	_
69-21	12140-12142	an	_
69-22	12143-12152	estimated	_
69-23	12153-12166	EEG-coherence	_
69-24	12167-12176	component	_
69-25	12177-12180	and	_
69-26	12181-12182	a	_
69-27	12183-12199	seed-correlation	_
69-28	12200-12203	map	_
69-29	12204-12213	component	_
69-30	12214-12217	are	_
69-31	12218-12228	correlated	_
69-32	12229-12235	across	_
69-33	12236-12239	all	_
69-34	12240-12252	participants	_
69-35	12253-12255	if	_
69-36	12256-12260	they	_
69-37	12261-12268	reflect	_
69-38	12269-12272	the	_
69-39	12273-12277	same	_
69-40	12278-12288	underlying	_
69-41	12289-12296	network	_
69-42	12297-12298	.	_

Text=In the parallel ICA model, we specified two groups (LTAA and NSAC) and two modalities (rs-fMRI NAcc seed correlation maps and EEG-coherence vectors).
70-1	12299-12301	In	_
70-2	12302-12305	the	_
70-3	12306-12314	parallel	_
70-4	12315-12318	ICA	_
70-5	12319-12324	model	_
70-6	12325-12326	,	_
70-7	12327-12329	we	_
70-8	12330-12339	specified	_
70-9	12340-12343	two	_
70-10	12344-12350	groups	_
70-11	12351-12352	(	_
70-12	12353-12357	LTAA	_
70-13	12358-12361	and	_
70-14	12362-12366	NSAC	_
70-15	12367-12368	)	_
70-16	12369-12372	and	_
70-17	12373-12376	two	_
70-18	12377-12387	modalities	_
70-19	12388-12389	(	_
70-20	12390-12397	rs-fMRI	_
70-21	12398-12402	NAcc	_
70-22	12403-12407	seed	_
70-23	12408-12419	correlation	_
70-24	12420-12424	maps	_
70-25	12425-12428	and	_
70-26	12429-12442	EEG-coherence	_
70-27	12443-12450	vectors	_
70-28	12451-12452	)	_
70-29	12453-12454	.	_

Text=We chose to use the default mask for the imaging data (only voxels with non-zero values for all subjects were included in the analysis) and the number of estimated components was restricted to 8 for each modality.
71-1	12455-12457	We	_
71-2	12458-12463	chose	_
71-3	12464-12466	to	_
71-4	12467-12470	use	_
71-5	12471-12474	the	_
71-6	12475-12482	default	_
71-7	12483-12487	mask	_
71-8	12488-12491	for	_
71-9	12492-12495	the	_
71-10	12496-12503	imaging	_
71-11	12504-12508	data	_
71-12	12509-12510	(	_
71-13	12511-12515	only	_
71-14	12516-12522	voxels	_
71-15	12523-12527	with	_
71-16	12528-12536	non-zero	_
71-17	12537-12543	values	_
71-18	12544-12547	for	_
71-19	12548-12551	all	_
71-20	12552-12560	subjects	_
71-21	12561-12565	were	_
71-22	12566-12574	included	_
71-23	12575-12577	in	_
71-24	12578-12581	the	_
71-25	12582-12590	analysis	_
71-26	12591-12592	)	_
71-27	12593-12596	and	_
71-28	12597-12600	the	_
71-29	12601-12607	number	_
71-30	12608-12610	of	_
71-31	12611-12620	estimated	_
71-32	12621-12631	components	_
71-33	12632-12635	was	_
71-34	12636-12646	restricted	_
71-35	12647-12649	to	_
71-36	12650-12651	8	_
71-37	12652-12655	for	_
71-38	12656-12660	each	_
71-39	12661-12669	modality	_
71-40	12670-12671	.	_

Text=Since data were from different modalities and the units of measurement were different, data were scaled to unit standard deviation, yielding z-scores.
72-1	12672-12677	Since	_
72-2	12678-12682	data	_
72-3	12683-12687	were	_
72-4	12688-12692	from	_
72-5	12693-12702	different	_
72-6	12703-12713	modalities	_
72-7	12714-12717	and	_
72-8	12718-12721	the	_
72-9	12722-12727	units	_
72-10	12728-12730	of	_
72-11	12731-12742	measurement	_
72-12	12743-12747	were	_
72-13	12748-12757	different	_
72-14	12758-12759	,	_
72-15	12760-12764	data	_
72-16	12765-12769	were	_
72-17	12770-12776	scaled	_
72-18	12777-12779	to	_
72-19	12780-12784	unit	_
72-20	12785-12793	standard	_
72-21	12794-12803	deviation	_
72-22	12804-12805	,	_
72-23	12806-12814	yielding	_
72-24	12815-12823	z-scores	_
72-25	12824-12825	.	_

Text=We optimized the parallel ICA using the correlation between mixing coefficients of the two modalities.
73-1	12826-12828	We	_
73-2	12829-12838	optimized	_
73-3	12839-12842	the	_
73-4	12843-12851	parallel	_
73-5	12852-12855	ICA	_
73-6	12856-12861	using	_
73-7	12862-12865	the	_
73-8	12866-12877	correlation	_
73-9	12878-12885	between	_
73-10	12886-12892	mixing	_
73-11	12893-12905	coefficients	_
73-12	12906-12908	of	_
73-13	12909-12912	the	_
73-14	12913-12916	two	_
73-15	12917-12927	modalities	_
73-16	12928-12929	.	_

Text=Using Bonferroni correction, the correlation between seed-correlation and EEG-coherence components were considered significant for p <0.05/64 = 0.0008 (there are 8 × 8 = 64 possible correlations between estimated ICA components).
74-1	12930-12935	Using	_
74-2	12936-12946	Bonferroni	_
74-3	12947-12957	correction	_
74-4	12958-12959	,	_
74-5	12960-12963	the	_
74-6	12964-12975	correlation	_
74-7	12976-12983	between	_
74-8	12984-13000	seed-correlation	_
74-9	13001-13004	and	_
74-10	13005-13018	EEG-coherence	_
74-11	13019-13029	components	_
74-12	13030-13034	were	_
74-13	13035-13045	considered	_
74-14	13046-13057	significant	_
74-15	13058-13061	for	_
74-16	13062-13063	p	_
74-17	13064-13065	<	_
74-18	13066-13073	0.05/64	_
74-19	13074-13075	=	_
74-20	13076-13082	0.0008	_
74-21	13083-13084	(	_
74-22	13085-13090	there	_
74-23	13091-13094	are	_
74-24	13095-13096	8	_
74-25	13097-13098	×	_
74-26	13099-13100	8	_
74-27	13101-13102	=	_
74-28	13103-13105	64	_
74-29	13106-13114	possible	_
74-30	13115-13127	correlations	_
74-31	13128-13135	between	_
74-32	13136-13145	estimated	_
74-33	13146-13149	ICA	_
74-34	13150-13160	components	_
74-35	13161-13162	)	_
74-36	13163-13164	.	_

Text=Similarly, using Bonferroni correction, group differences in the loading parameters for components were considered significant for p <0.05/8 = 0.006 (group differences tested for 8 possible EEG or seed-correlation components).
75-1	13165-13174	Similarly	_
75-2	13175-13176	,	_
75-3	13177-13182	using	_
75-4	13183-13193	Bonferroni	_
75-5	13194-13204	correction	_
75-6	13205-13206	,	_
75-7	13207-13212	group	_
75-8	13213-13224	differences	_
75-9	13225-13227	in	_
75-10	13228-13231	the	_
75-11	13232-13239	loading	_
75-12	13240-13250	parameters	_
75-13	13251-13254	for	_
75-14	13255-13265	components	_
75-15	13266-13270	were	_
75-16	13271-13281	considered	_
75-17	13282-13293	significant	_
75-18	13294-13297	for	_
75-19	13298-13299	p	_
75-20	13300-13301	<	_
75-21	13302-13308	0.05/8	_
75-22	13309-13310	=	_
75-23	13311-13316	0.006	_
75-24	13317-13318	(	_
75-25	13319-13324	group	_
75-26	13325-13336	differences	_
75-27	13337-13343	tested	_
75-28	13344-13347	for	_
75-29	13348-13349	8	_
75-30	13350-13358	possible	_
75-31	13359-13362	EEG	_
75-32	13363-13365	or	_
75-33	13366-13382	seed-correlation	_
75-34	13383-13393	components	_
75-35	13394-13395	)	_
75-36	13396-13397	.	_

Text=Although the loading parameters estimate the overall contribution of every voxel or coherence of an estimated component to each subject's seed-correlation or coherence map, many of the voxels or coherences have relatively very small magnitude contribution to the component, although they can be presumed to covary jointly.
76-1	13398-13406	Although	_
76-2	13407-13410	the	_
76-3	13411-13418	loading	_
76-4	13419-13429	parameters	_
76-5	13430-13438	estimate	_
76-6	13439-13442	the	_
76-7	13443-13450	overall	_
76-8	13451-13463	contribution	_
76-9	13464-13466	of	_
76-10	13467-13472	every	_
76-11	13473-13478	voxel	_
76-12	13479-13481	or	_
76-13	13482-13491	coherence	_
76-14	13492-13494	of	_
76-15	13495-13497	an	_
76-16	13498-13507	estimated	_
76-17	13508-13517	component	_
76-18	13518-13520	to	_
76-19	13521-13525	each	_
76-20	13526-13533	subject	_
76-21	13534-13536	's	_
76-22	13537-13553	seed-correlation	_
76-23	13554-13556	or	_
76-24	13557-13566	coherence	_
76-25	13567-13570	map	_
76-26	13571-13572	,	_
76-27	13573-13577	many	_
76-28	13578-13580	of	_
76-29	13581-13584	the	_
76-30	13585-13591	voxels	_
76-31	13592-13594	or	_
76-32	13595-13605	coherences	_
76-33	13606-13610	have	_
76-34	13611-13621	relatively	_
76-35	13622-13626	very	_
76-36	13627-13632	small	_
76-37	13633-13642	magnitude	_
76-38	13643-13655	contribution	_
76-39	13656-13658	to	_
76-40	13659-13662	the	_
76-41	13663-13672	component	_
76-42	13673-13674	,	_
76-43	13675-13683	although	_
76-44	13684-13688	they	_
76-45	13689-13692	can	_
76-46	13693-13695	be	_
76-47	13696-13704	presumed	_
76-48	13705-13707	to	_
76-49	13708-13714	covary	_
76-50	13715-13722	jointly	_
76-51	13723-13724	.	_

Text=Therefore, to aid in visualization, each component was scaled to unit standard deviation, yielding z-score “ networks ”, then thresholded at | z |> 1.96, highlighting the largest magnitude contributions to each component.
77-1	13725-13734	Therefore	_
77-2	13735-13736	,	_
77-3	13737-13739	to	_
77-4	13740-13743	aid	_
77-5	13744-13746	in	_
77-6	13747-13760	visualization	_
77-7	13761-13762	,	_
77-8	13763-13767	each	_
77-9	13768-13777	component	_
77-10	13778-13781	was	_
77-11	13782-13788	scaled	_
77-12	13789-13791	to	_
77-13	13792-13796	unit	_
77-14	13797-13805	standard	_
77-15	13806-13815	deviation	_
77-16	13816-13817	,	_
77-17	13818-13826	yielding	_
77-18	13827-13834	z-score	_
77-19	13835-13836	“	_
77-20	13837-13845	networks	_
77-21	13846-13847	”	_
77-22	13848-13849	,	_
77-23	13850-13854	then	_
77-24	13855-13866	thresholded	_
77-25	13867-13869	at	_
77-26	13870-13871	|	_
77-27	13872-13873	z	_
77-28	13874-13875	|	_
77-29	13876-13877	>	_
77-30	13878-13882	1.96	_
77-31	13883-13884	,	_
77-32	13885-13897	highlighting	_
77-33	13898-13901	the	_
77-34	13902-13909	largest	_
77-35	13910-13919	magnitude	_
77-36	13920-13933	contributions	_
77-37	13934-13936	to	_
77-38	13937-13941	each	_
77-39	13942-13951	component	_
77-40	13952-13953	.	_

